Napredna pretraga

Pregled bibliografske jedinice broj: 527708

Proliferative and kinetics parameters in patients with chronic lymphocytic leukemia and low total tumor mass


Kardum-Skelin, Ika; Jelic Puskaric, Biljana; Pazur, Marina; Jakšić, Ozren; Kardum, Matko; Vrhovac, Radovan; Ostojic Kolonic, Slobodanka; Radic-Kristo, Delfa; Jakšić, Branimir
Proliferative and kinetics parameters in patients with chronic lymphocytic leukemia and low total tumor mass // BAC Journal of the British Association for Cytopathology, 22 (Suppl.1) / Herbert, Amanda (ur.).
Oxford: Willey-Blackwell, 2011. str. 46-46 (predavanje, međunarodna recenzija, sažetak, znanstveni)


Naslov
Proliferative and kinetics parameters in patients with chronic lymphocytic leukemia and low total tumor mass

Autori
Kardum-Skelin, Ika ; Jelic Puskaric, Biljana ; Pazur, Marina ; Jakšić, Ozren ; Kardum, Matko ; Vrhovac, Radovan ; Ostojic Kolonic, Slobodanka ; Radic-Kristo, Delfa ; Jakšić, Branimir

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
BAC Journal of the British Association for Cytopathology, 22 (Suppl.1) / Herbert, Amanda - Oxford : Willey-Blackwell, 2011, 46-46

Skup
36th European Congress of Cytology

Mjesto i datum
Istanbul, Turska, 22-25.09.2011

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Chronic lymphocytic leukemia; low tumor mass; DTM; DTL; image analysis

Sažetak
Chronic lymphocytic leukemia (CLL) is characterized by low proliferative activity and an indolent low-grade clinical disease course. The clinical stages and other parameters used to date have been unable to identify patients at a high risk of disease progression. Therefore, additional parameters have been identified allowing a more accurate prediction of the prognosis of CLL patients. The aim of the study was to find new morphometric, proliferative and/or kinetic parameters in different tumor mass compartments, i.e. bone marrow, peripheral blood and lymph node, which would be able to predict benefit of early therapeutic approach in early stages of the disease. In 47 CLL untreated patients, with low total tumor mass (TTM<9), tumor doubling time (DTM) and lymphocyte doubling time (DTL) has been calculated. The results showed that lymphatic cells contained mainly small homogeneous AgNOR-e without inhomogeneous or anullar types, and a smaller percentage of cells in S-phase cell cycle, if the DTL and DTM were less than 12 months. Significant image parameters correlating with DTM were found in the lymphoid cells of bone marrow, peripheral blood and lymph nodes ; those correlating with DTL were mostly in the lymphoid cells of peripheral blood, less in lymph node, and very rarely in bone marrow. The morphometric characteristics of homogeneous, inhomogeneous and annular AgNOR, and characteristics of diploid histogram have confirmed the hypothesis that prognostically unfavorable and favorable subgroups could be identified and the course of the disease predicted even within the groups of neoplasms of relatively low malignancy.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
044-0000000-3455 - Dijagnostika i terapija infekcija kod imunokompromitiranih bolesnika (Radovan Vrhovac, )
053-0531854-1850 - Hranidbeno metaboličke osnove podizanja kvalitete animalnih namirnica (Nina Poljičak Milas, )
108-1081873-1893 - Prognostički faktori, dijagnostika i terapija hemoblastoza (Branimir Jakšić, )
198-1980955-0953 - Imunobiologija kronične B-limfocitne leukemije i mikrookoliš (Ozren Jakšić, )

Ustanove
Klinička bolnica "Merkur",
Veterinarski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE